FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading
Top Cited Papers
- 1 September 2007
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (12), 1933-1942
- https://doi.org/10.1007/s00259-007-0534-y
Abstract
Treatment and prognosis of gliomas depend on their histological tumour grade. The aim of the study was to evaluate the potential of [(18)F]fluoroethyltyrosine (FET) PET for non-invasive tumour grading in untreated patients. Dynamic FET PET studies were performed in 54 patients who, based on MRI, were estimated to have low grade (LG; n = 20), intermediate (WHO II-III; n = 4) or high grade (HG; n = 30) tumours. For standard evaluation, tumour SUV(max) and the ratio to background (SUV(max)/BG) were calculated (sum image: 20-40 min). For dynamic evaluation, mean SUV values within a 90% isocontour ROI (SUV90) and the SUV90/BG ratios were determined for each time frame to evaluate the course of FET uptake. Results were correlated with histopathological findings from PET-guided stereotactic biopsies. Histology revealed gliomas in all patients. Using the standard method a statistically significant difference (p = 0.001) was found between LG (n = 20; SUV(max)/BG: 2.16 +/- 0.98) and HG (n = 34; SUV(max)/BG: 3.29 +/- 1.06) gliomas (opt. threshold 2.58: SN71%/SP85%/area under ROC curve [AUC]:0.798), however, with a marked overlap between WHO II to IV tumours. Time activity curves showed slight increase in LG, whereas HG tumours presented with an early peak (10-20 min) followed by a decrease. Dynamic evaluation successfully separated LG from HG gliomas with higher diagnostic accuracy (SN94%/SP100%/AUC:0.967). Based on the ratio-based method, a statistically significant difference was found between LG and HG gliomas. Due to the interindividual variability, however, no reliable individual grading was possible. In contrast, dynamic evaluation allowed LG and HG gliomas to be differentiated with high diagnostic power and, thus, should supplement the conventional method.Keywords
This publication has 39 references indexed in Scilit:
- Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomasJournal of the Neurological Sciences, 2006
- Positron Emission Tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus Magnetic Resonance Imaging in the Diagnosis of Recurrent GliomasNeurosurgery, 2005
- Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission TomographyClinical Cancer Research, 2004
- Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography—guided stereotactic brain biopsiesJournal of Neurosurgery, 2004
- Positron emission tomography with injection of methionine as a prognostic factor in gliomaJournal of Neurosurgery, 2001
- “Facilitated” Amino Acid Transport is Upregulated in Brain TumorsJournal of Cerebral Blood Flow & Metabolism, 1998
- [11C]l-Methionine Uptake in GliomasNeurosurgery, 1989
- [11C]L-methionine uptake in gliomasNeurosurgery, 1989
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- ROC Analysis Applied to the Evaluation of Medical Imaging TechniquesInvestigative Radiology, 1979